(VIANEWS) – Riot Blockchain (RIOT), Pfizer (PFE), Canadian Natural Resources Limited (CNQ) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Riot Blockchain (RIOT)

1611.2% sales growth and 7.84% return on equity

Riot Blockchain’s sales growth this year is anticipated to be 1681.8% and 94.4% for next year.

Year-on-year quarterly revenue growth grew by 1668.7%, now sitting on 65.3M for the twelve trailing months.

Volume

Today’s last reported volume for Riot Blockchain is 16667900 which is 21.35% above its average volume of 13734900.

Riot Blockchain’s sales growth is a negative 0% for the ongoing quarter and 1611.2% for the next. The company’s growth estimates for the current quarter and the next is 700% and 125%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.84%.

Volatility

Riot Blockchain’s last day, last week, and last month’s current intraday variation average was 16.54%, 8.04%, and 4.86%, respectively.

Riot Blockchain’s highest amplitude of average volatility was 13.83% (day), 11.63% (last week), and 9.54% (last month), respectively.

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $14.99 at 10:22 EST, way below its 52-week high of $79.50 and way higher than its 52-week low of $8.90.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is way below its 50-day moving average of $31.38 and way under its 200-day moving average of $35.49.

Previous days news about Riot Blockchain(RIOT)

  • According to Bloomberg Quint on Thursday, 20 January, "Marathon Digital Holdings Inc. had a 3.5 exahash rate at the end of December, and Riot Blockchain Inc., 3.1 exahash, respectively, though both companies have projected sharp gains in processing power for the coming year."
  • According to Bloomberg Quint on Friday, 21 January, "Mining companies Riot Blockchain Inc. and Marathon Digital Holdings Inc. traded6.6%and6.0%lower respectively on Friday, while major Bitcoin holder MicroStrategy Inc. shed9.4%. "

2. Pfizer (PFE)

108.8% sales growth and 14.03% return on equity

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.

Pfizer’s sales growth this year is expected to be 91.3% and a negative 12.9% for next year.

Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 40580700 which is 6.97% below its average volume of 43622600.

Pfizer’s sales growth for the next quarter is 108.8%. The company’s growth estimates for the present quarter and the next is 50% and 150%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

Volatility

Pfizer’s last day, last week, and last month’s current intraday variation average was 2.39%, 1.55%, and 1.21%, respectively.

Pfizer’s highest amplitude of average volatility was 4.59% (day), 3.30% (last week), and 2.70% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $52.79 at 10:22 EST, higher than its 52-week high of $51.86.

Pfizer’s Moving Average

Pfizer’s worth is way above its 50-day moving average of $43.57 and way higher than its 200-day moving average of $42.49.

Previous days news about Pfizer(PFE)

  • According to MarketWatch on Monday, 17 January, "Driving the FTSE 100 higher and at the top of the Stoxx Europe 600’s gainer’s list, was GlaxoSmithKline , up 5% after saying Saturday that it has rejected an unsolicited £50 billion ($68.4 billion) Unilever offer for the unit behind painkiller Advil and Sensodyne toothpaste that it jointly owns with Pfizer . "
  • According to The Wall Street Journal on Monday, 17 January, "The maker of Hellmann’s mayonnaise and other consumer staples on Saturday confirmed a report in the London-based Sunday Times that it made an offer for the joint venture between Glaxo and Pfizer that makes Centrum vitamins and Panadol painkillers. "
  • According to The Wall Street Journal on Monday, 17 January, "The strategic update Monday came days after Unilever said it had approached GlaxoSmithKline PLC and Pfizer Inc. about buying their consumer-healthcare joint venture, GSK Consumer Healthcare. "
  • According to Bloomberg Quint on Monday, 17 January, "But already, Unilever is finding itself on the defensive after talks of a purchase of Glaxo’s consumer health business — in which Pfizer Inc. still has a stake — surfaced. "

3. Canadian Natural Resources Limited (CNQ)

34.1% sales growth and 12.28% return on equity

Canadian Natural Resources Limited explores for, develops, produces, and markets crude oil, natural gas, and natural gas liquids (NGLs).

Canadian Natural Resources Limited’s sales growth this year is anticipated to be 21.5% and 0.5% for next year.

Year-on-year quarterly revenue growth grew by 127.3%, now sitting on 22.66B for the twelve trailing months.

Volume

Today’s last reported volume for Canadian Natural Resources Limited is 5457080 which is 72.98% above its average volume of 3154750.

Canadian Natural Resources Limited’s sales growth for the next quarter is 34.1%. The company’s growth estimates for the present quarter and the next is 145% and 108.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.28%.

Volatility

Canadian Natural Resources Limited’s last day, last week, and last month’s current intraday variation average was 3.90%, 1.98%, and 1.75%, respectively.

Canadian Natural Resources Limited’s highest amplitude of average volatility was 3.56% (day), 2.81% (last week), and 2.51% (last month), respectively.

Canadian Natural Resources Limited’s Stock Yearly Top and Bottom Value

Canadian Natural Resources Limited’s stock is valued at $50.79 at 10:22 EST, way above its 52-week high of $44.33.

Canadian Natural Resources Limited’s Moving Average

Canadian Natural Resources Limited’s value is way above its 50-day moving average of $40.38 and way higher than its 200-day moving average of $35.61.

4. AtriCure (ATRC)

27.8% sales growth and 10.02% return on equity

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally.

AtriCure’s sales growth this year is expected to be 32.3% and 17.6% for next year.

Year-on-year quarterly revenue growth grew by 28.7%, now sitting on 258.84M for the twelve trailing months.

Volume

Today’s last reported volume for AtriCure is 180210 which is 23.07% below its average volume of 234267.

AtriCure’s sales growth is a negative 0% for the present quarter and 27.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 200% and negative -3.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.02%.

Volatility

AtriCure’s last day, last week, and last month’s current intraday variation average was 3.05%, 2.32%, and 2.92%, respectively.

AtriCure’s highest amplitude of average volatility was 4.37% (day), 4.67% (last week), and 5.48% (last month), respectively.

AtriCure’s Stock Yearly Top and Bottom Value

AtriCure’s stock is valued at $69.28 at 10:22 EST, way below its 52-week high of $89.18 and way above its 52-week low of $52.81.

AtriCure’s Moving Average

AtriCure’s value is below its 50-day moving average of $73.22 and below its 200-day moving average of $73.66.

5. Coastal Financial Corporation (CCB)

25.1% sales growth and 16.45% return on equity

Coastal Financial Corporation’s sales growth this year is expected to be 39.3% and 24% for next year.

Year-on-year quarterly revenue growth grew by 66.4%, now sitting on 83.92M for the twelve trailing months.

Volume

Today’s last reported volume for Coastal Financial Corporation is 168433 which is 296.93% above its average volume of 42433.

Coastal Financial Corporation’s sales growth for the next quarter is 25.1%. The company’s growth estimates for the present quarter and the next is 34.2% and negative -20.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.45%.

Volatility

Coastal Financial Corporation’s last day, last week, and last month’s current intraday variation average was 0.17%, 0.68%, and 2.02%, respectively.

Coastal Financial Corporation’s highest amplitude of average volatility was 4.29% (day), 3.25% (last week), and 4.79% (last month), respectively.

Coastal Financial Corporation’s Stock Yearly Top and Bottom Value

Coastal Financial Corporation’s stock is valued at $51.87 at 10:22 EST, below its 52-week high of $54.41 and way above its 52-week low of $19.61.

Coastal Financial Corporation’s Moving Average

Coastal Financial Corporation’s worth is way higher than its 50-day moving average of $46.33 and way higher than its 200-day moving average of $34.22.

6. Raymond James Financial (RJF)

22.8% sales growth and 14.48% return on equity

Raymond James Financial, Inc., through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities in the United States, Canada, and Europe.

Raymond James Financial’s sales growth this year is anticipated to be 20.3% and 9.3% for next year.

Year-on-year quarterly revenue growth grew by 25.7%, now sitting on 8.46B for the twelve trailing months.

Volume

Today’s last reported volume for Raymond James Financial is 1255880 which is 20.8% above its average volume of 1039630.

Raymond James Financial’s sales growth for the next quarter is 22.8%. The company’s growth estimates for the current quarter and the next is 39.9% and 10.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.48%.

Volatility

Raymond James Financial’s last day, last week, and last month’s current intraday variation average was 3.56%, 2.18%, and 1.47%, respectively.

Raymond James Financial’s highest amplitude of average volatility was 3.51% (day), 3.41% (last week), and 2.46% (last month), respectively.

Raymond James Financial’s Stock Yearly Top and Bottom Value

Raymond James Financial’s stock is valued at $98.16 at 10:22 EST, below its 52-week high of $103.46 and way above its 52-week low of $54.51.

Raymond James Financial’s Moving Average

Raymond James Financial’s worth is higher than its 50-day moving average of $97.63 and higher than its 200-day moving average of $90.88.

7. Rogers Corporation (ROG)

15.4% sales growth and 6.87% return on equity

Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide.

Rogers Corporation’s sales growth this year is expected to be 18% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 15.3%, now sitting on 833.04M for the twelve trailing months.

Volume

Today’s last reported volume for Rogers Corporation is 40459 which is 88.76% below its average volume of 360131.

Rogers Corporation’s sales growth for the next quarter is 15.4%. The company’s growth estimates for the ongoing quarter and the next is 22.8% and 16.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.87%.

Volatility

Rogers Corporation’s last day, last week, and last month’s current intraday variation average was 0.03%, 0.10%, and 0.24%, respectively.

Rogers Corporation’s highest amplitude of average volatility was 0.49% (day), 0.40% (last week), and 0.52% (last month), respectively.

Rogers Corporation’s Stock Yearly Top and Bottom Value

Rogers Corporation’s stock is valued at $272.60 at 10:22 EST, under its 52-week high of $274.14 and way higher than its 52-week low of $147.93.

Rogers Corporation’s Moving Average

Rogers Corporation’s worth is higher than its 50-day moving average of $259.14 and way higher than its 200-day moving average of $209.39.

8. L.B. Foster Company (FSTR)

9.9% sales growth and 3.43% return on equity

L.B. Foster Company provides products and services for the rail industry and solutions to support critical infrastructure projects worldwide.

L.B. Foster Company’s sales growth this year is expected to be 11% and 0.3% for next year.

Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 516.23M for the twelve trailing months.

Volume

Today’s last reported volume for L.B. Foster Company is 9370 which is 73.28% below its average volume of 35071.

L.B. Foster Company’s sales growth for the next quarter is 9.9%. The company’s growth estimates for the current quarter and the next is a negative 5% and 191.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.43%.

Volatility

L.B. Foster Company’s last day, last week, and last month’s current intraday variation average was 0.79%, 1.65%, and 2.17%, respectively.

L.B. Foster Company’s highest amplitude of average volatility was 1.44% (day), 2.70% (last week), and 4.46% (last month), respectively.

L.B. Foster Company’s Stock Yearly Top and Bottom Value

L.B. Foster Company’s stock is valued at $14.06 at 10:22 EST, way under its 52-week high of $19.47 and way above its 52-week low of $12.62.

L.B. Foster Company’s Moving Average

L.B. Foster Company’s worth is under its 50-day moving average of $15.17 and way under its 200-day moving average of $16.67.

LEAVE A REPLY

Please enter your comment!
Please enter your name here